Loading...
Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection Fraction
IMPORTANCE: Sacubitril-valsartan use reduces mortality and hospitalizations compared with enalapril among patients with chronic heart failure with reduced ejection fraction (HFrEF); however, the cost-effectiveness of these treatments when initiated during hospitalization for HF is unknown. OBJECTIVE...
Na minha lista:
| Udgivet i: | JAMA Cardiol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Medical Association
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7675099/ https://ncbi.nlm.nih.gov/pubmed/32785628 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2020.2822 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|